Schedule for Master Class On Demand Learning

• Registration and Breakfast

• Welcome and Opening Remarks

Session 1 - Malignant and Non-Malignant Hematology

• Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach

  Ann S. LaCasce MD, MMSC

• Myeloid Malignancies: Molecular Markets and Targeted Therapies

  Daniel J. DeAngelo, MD, PhD

• Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management

  Ayalew Tefferi, MD

• Multiple Myeloma: Current Evidence-Based Management

  Kenneth C. Anderson, MD

• Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape

  Matthew S. Davids MD, MMSC

• Refreshment Break

• Current and Future Treatment Strategies for Cancer Associated Thrombosis

  Jean M. Connors MD

• Reducing the Sickle Cell Disease Burden with Novel Treatment Targets

  Alexis A. Thompson MD, MPH

• Panel Discussion

  All Faculty

• Lunch

Session 2 – Women’s Cancers and Supportive Care

Supportive Care

• Sexual Health in Cancer Survivors

  Sharon L. Bober, PhD

• Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes

  Janet L. Abrahm, MD

• Supportive Care Questions and Answers

• Refreshment Break

Breast Cancers

• HER2-Positive Breast Cancer and Triple-Negative Breast Cancer: An Evolving Treatment Landscape

  Nancy U. Lin MD

• Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes

  Harold J. Burstein MD, PhD

Gynecologic Cancers

• Molecular Advances and Emerging Treatment Strategies In Ovarian Cancer

  Ursula A. Matulonis, MD

• Molecular Advances and Emerging Treatment Strategies In Endometrial Cancer

  Joyce F. Liu, MD, MPH

• Panel Discussion

  All Faculty

• Day One Adjournment

• Registration and Breakfast

• Welcome Back

Session 3 – Gastrointestinal Cancers and Sarcoma

Gastrointestinal Cancers

• Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment

  Robert J. Mayer MD

• Novel Treatments for Neuroendocrine Tumors: Using Patient and Tumor Characteristics to Guide Treatments

  Jennifer A. Chan, MD, MPH

• Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers

  Peter C. Enzinger, MD

• Hepatobiliary Cancer: Predictive Biomarkers, Novel Agents, and Patient Monitoring

  Thomas A. Abrams, MD

• Refreshment Break

• Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy

  Matthew B. Yurgelun, MD

• Panel Discussion

  All Faculty

Sarcoma

• Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma

  George D. Demetri, MD

• Sarcoma Questions and Answers

• Lunch

Session 4 – Head, Neck and Lung Cancers and Melanoma

Head, Neck and Lung Cancers

• Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers

  Robert I. Haddad, MD

• NSCLC and SCLC: Molecular Testing and Emerging Treatment Options

  Bruce E. Johnson MD

Melanoma Cancer

• Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma

  F. Stephen Hodi, MD

• Panel Discussion

  All Faculty

• Refreshment Break

Session 5 – Genitourinary Cancers

• Prostate Cancer: An Evolving Treatment Landscape

  Mary Ellen Taplin, MD

• Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice

  Robert Dreicer, MD

• Panel Discussion

  All Faculty

• Closing Remarks

• Course Adjournment